ACTIVE

Medisch Labo Bruyland

Export PDF

Financial year 2024 · Closed on 31/12/2024

Net result4,9 M €-3,8 %over 1 year
Revenue24,2 M €+0,1 %over 1 year
Equity8,2 M €-52,8 %over 1 year
Workforce51,4 ETP-4,3 %over 1 year

Identity

Source · BCE/KBO

Medisch Labo Bruyland is a Private limited company incorporated in 1981. Its main activity is: Pre-primary education. Its registered office is in Kortrijk. It employs on average 51,4 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0421.609.114
Incorporation
24/04/1981
Legal form
Private limited company
Registered office
Beneluxpark(Kor) 2
8500 Kortrijk · FlandreSee on map
Contributed capital
25 893,78 €
Latest accounts
31/12/2024
Average workforce
51,4 ETP
Joint committees (3)
  • 30502
  • 330
  • 33004
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debtsHigh revenue

Financials

Source · NBB, 19 filings

Trend over 5 financial years

20242023202220212007
Income statement
Revenue24,2 M €24,2 M €25,6 M €50,1 M €10,6 M €
EBITDA6,3 M €7 M €7 M €14,3 M €3,2 M €
Operating result6,1 M €6,6 M €6,6 M €13,7 M €2,4 M €
Net result4,9 M €5,1 M €4,9 M €10,1 M €1,5 M €
Balance sheet
Equity8,2 M €17,4 M €12,4 M €7,7 M €3,9 M €
Total assets15,4 M €24,9 M €20,6 M €20 M €10,3 M €
Cash5 M €4,5 M €8,7 M €8,6 M €891,5 k €
Debts7 M €7,2 M €7,9 M €12,4 M €6,3 M €
Other
Workforce51,4 ETP53,7 ETP59,8 ETP59,2 ETP59,6 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 50 M€ and 100 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2024

2 active · 13 ended

Active mandates

B Medical Advice

Director · since 01 avril 2008 · 0895.793.911

Represented by Karen BRUYLAND

Active
RADON

Director · since 01 avril 2008 · 0419.884.393

Represented by Sven Bruyland

Active

Ended mandates

RADON

Manager · since 20 décembre 2019 · 0419.884.393

Represented by Sven Bruyland

Ended
B Medical Advice

Manager · since 01 avril 2008 · 0895.793.911

Represented by Bruyland Karen

Ended
B Medical Advice

Manager · since 01 avril 2008 · 0895.793.911

Represented by Karen Bruyland

Ended
B Medical Advice

Manager · since 01 avril 2008 · 0895.793.911

Represented by Karen Bruyland

Ended

Other companies at this address

Beneluxpark(Kor) 2 8500 Kortrijk
CompanyCBE no.
Medlab● Active
0554.893.547
T4Construction● Active
0800.262.074

Full financial information

Source · NBB
202420232022202120202019
Type of accountFull modelFull modelFull modelFull modelFull modelFull model
Start of the financial year01/01/202401/01/202301/01/202201/07/202001/07/201901/07/2018
Closing of the financial year31/12/202431/12/202331/12/202231/12/202130/06/202030/06/2019
Length of the financial year12 months12 months12 months18 months12 months12 months
Filing date31/07/202513/08/202431/07/202306/07/202229/01/202130/01/2020
General meeting31/07/202522/07/202422/07/202316/06/202230/12/202021/01/2020
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 19 filings
ModelClosingGeneral meetingFiledLanguageDocument
Full model31/12/202431/07/202531/07/2025DutchPDF
Full model31/12/202322/07/202413/08/2024DutchPDF
Full model31/12/202222/07/202331/07/2023DutchPDF
Full model31/12/202116/06/202206/07/2022DutchPDF
Full model30/06/202030/12/202029/01/2021DutchPDF
Full model30/06/201921/01/202030/01/2020DutchPDF
Full model30/06/201828/01/201930/01/2019DutchPDF
Full model30/06/201716/12/201711/01/2018DutchPDF
Full model30/06/201617/12/201612/01/2017DutchPDF
Full model30/06/201519/12/201513/01/2016DutchPDF
Full model30/06/201420/12/201419/01/2015DutchPDF
Full model30/06/201321/12/201323/12/2013DutchPDF
Full model30/06/201215/12/201220/12/2012DutchPDF
Full model30/06/201109/02/201223/02/2012DutchPDF
Full model30/06/201025/11/201014/02/2011DutchPDF
Full model30/06/200920/01/201009/02/2010DutchPDF
Full model30/06/200810/01/200917/02/2009DutchPDF
Full model30/06/200715/12/200714/01/2008DutchPDF
Full model30/06/200616/12/200603/01/2007DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 50 M€ and 100 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2024

2 active · 13 ended

Active mandates

B Medical Advice

Director · since 01 avril 2008 · 0895.793.911

Represented by Karen BRUYLAND

Active
RADON

Director · since 01 avril 2008 · 0419.884.393

Represented by Sven Bruyland

Active

Ended mandates

RADON

Manager · since 20 décembre 2019 · 0419.884.393

Represented by Sven Bruyland

Ended
B Medical Advice

Manager · since 01 avril 2008 · 0895.793.911

Represented by Bruyland Karen

Ended
B Medical Advice

Manager · since 01 avril 2008 · 0895.793.911

Represented by Karen Bruyland

Ended
B Medical Advice

Manager · since 01 avril 2008 · 0895.793.911

Represented by Karen Bruyland

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates15/09/2023
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates26/07/2021
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN - ALGEMENE VERGADERING - BOEKJAAR
    PDF
  • Mandates18/03/2020
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Registered office27/06/2018
    MAATSCHAPPELIJKE ZETEL
    PDF
  • Restructuring22/01/2018
    RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
    PDF
  • Restructuring11/10/2017
    RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
    PDF
  • Mandates27/01/2017
    ONTSLAGEN - BENOEMINGEN - DIVERSEN
    PDF
  • Mandates07/01/2014
    ONTSLAGEN - BENOEMINGEN
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2024
    Annual accounts 20244,9 M €↓
  2. 2023
    Annual accounts 20235,1 M €↑
  3. 2022
    Annual accounts 20224,9 M €↓
  4. 2021
    Annual accounts 202110,1 M €↑
  5. 2007
    Annual accounts 20071,5 M €
  6. 24/04/1981
    IncorporationPrivate limited company